Fundraising FoxLilly Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsNew Enterprise Associates (NEA)ForbionNovo Holdings
Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds.
BiotechDeep TechNew Haven, US
Craig Crews(Co-Founder & Scientific Advisor)inMikael Dolsten, M.D., Ph.D.(Co-founder and Executive Chairman of the Board)Craig Crews, Ph.D.(Co-Founder & Scientific Advisor)Dan McHugh(Manager)Tim Shannon(CEO and Board Member)inJeanne Magram(Chief Scientific Officer)in
Co-investorsYosemiteF-Prime CapitalCanaan Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.